LB Pharmaceuticals (LBRX) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced at 9:30 A.M. on June 3rd, 2026, with polls opened for voting on all matters.

• Board members, executive team, auditors, and legal counsel were introduced.

• The meeting followed the agenda set forth in the notice and proxy statement, with two proposals to be considered.

Board and executive committee updates

• Board members and executive officers were introduced, including key roles such as Chief Operating Business Officer, Chief Commercial Officer, and Senior Vice Presidents across various functions.

Shareholder proposals

• Two proposals were presented: election of three Class I directors and ratification of the independent auditor.

• Nominees for Class I director were Dr. Robert Lenz, Rebecca Luse, and Ran Nussbaum.

• Proposal to ratify BDO USA, P.C. as the independent registered public accounting firm for fiscal year 2026.